Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 1.00 |
| ▸ | F2 | P00734 | 3/20 | 0.77 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8354752 | 0.89 | F10 (0.81) | F10F2SLC29A1 | |
| SCHEMBL5641465 | 0.89 | F10 (1.00) | F10F2SLC29A1 | |
| SCHEMBL14348232 | 0.88 | F10 (0.78) | F10F2SLC29A1 | |
| SCHEMBL5643320 | 0.87 | F10 (1.00) | F10F2SLC29A1 | |
| SCHEMBL5643433 | 0.86 | F10 (1.00) | F10F2SLC29A1 | |
| SCHEMBL5644200 | 0.86 | F10 (1.00) | F10F2SLC29A1 | |
| SCHEMBL5642262 | 0.86 | F10 (1.00) | F10F2SLC29A1 | |
| SCHEMBL15174759 | 0.85 | F10 (0.80) | F10F2SLC29A1 | |
| SCHEMBL5641829 | 0.85 | F10 (1.00) | F10F2SLC29A1 | |
| SCHEMBL5643471 | 0.85 | F10 (0.85) | F10F2SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312214-B2 | 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-12-25 | — | — | US | disclosed |
| US-7312214-B2 | 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-12-25 | — | — | US | disclosed |
| WO-2003099276-A1 | 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |